Findings

What do systematic reviews say?

1,060 questions · 1,105 findings · 84 reviews · Metabolic and Endocrine Disorders

Sort:Best matchNewestHighest certainty Download CSV

No studies found 434 · 39.3%GRADE not reported 32 · 2.9%Very low 246 · 22.3%Low 237 · 21.4%Moderate 132 · 11.9%High 24 · 2.2%

Intervention not reported

Reported cut‐off value (range basal calcitonin 4.6 pg/mL to 35 pg/mL, range stimulated calcitonin 50 pg/mL to 100 pg/mL)

1 finding from 1 review

Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules 2020 · Cochrane Headline outcomes only
no estimate extracted
13 studies · 69702 participants
GRADE not reported

Intervention not reported

Subgroup analysis

The review found no eligible studies for this question.

1 finding from 1 review

Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Cut‐off value

The review found no eligible studies for this question.

1 finding from 1 review

Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

pg/mL

1 finding from 1 review

Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules 2020 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 44393 participants
GRADE not reported

Intervention not reported

Gender (basal calcitonin)

The review found no eligible studies for this question.

1 finding from 1 review

Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Female

1 finding from 1 review

Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules 2020 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 14858 participants
GRADE not reported

Intervention not reported

Male

1 finding from 1 review

Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules 2020 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 4339 participants
GRADE not reported

Minimally invasive parathyroidectomy vs bilateral neck exploration

Success rate (eucalcaemia) (a)

It is very uncertain whether minimally invasive parathyroidectomy changes success rate (eucalcaemia) (a) compared with bilateral neck exploration (very low certainty).

1 finding from 1 review

Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative… 2020 · Cochrane Headline outcomes only
RR 0.98 [0.94, 1.03]
5 studies · 266 participants
Very low

Minimally invasive parathyroidectomy vs bilateral neck exploration

Adverse effects: perioperative complications (number of events)

Minimally invasive parathyroidectomy may leads to lower total incidence of perioperative adverse events (number) compared with bilateral neck exploration (low certainty).

1 finding from 1 review

Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative… 2020 · Cochrane Headline outcomes only
RR 0.5 [0.33, 0.76]
5 studies · 236 participants
Low

Minimally invasive parathyroidectomy vs bilateral neck exploration

All‐cause mortality

1 finding from 1 review

Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Minimally invasive parathyroidectomy vs bilateral neck exploration

Health‐related quality of life

1 finding from 1 review

Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Minimally invasive parathyroidectomy vs bilateral neck exploration

Cosmetic satisfaction

1 finding from 1 review

Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Minimally invasive parathyroidectomy vs bilateral neck exploration

Operating time

1 finding from 1 review

Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative… 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 171 participants
Very low

Minimally invasive parathyroidectomy vs bilateral neck exploration

Length of hospital stay

The review found no eligible studies for this question.

1 finding from 1 review

Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs

Diabetes complications

The review found no eligible studies for this question.

1 finding from 1 review

Resveratrol for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs

All‐cause mortality

1 finding from 1 review

Resveratrol for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 50 participants
Very low

Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs

Diabetes‐related mortality

1 finding from 1 review

Resveratrol for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 50 participants
Very low

Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Resveratrol for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs

Adverse events

1 finding from 1 review

Resveratrol for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 50 participants
Very low

Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs

HbA1c (%)

1 finding from 1 review

Resveratrol for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 31 participants
Very low